Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
26.68
+0.41 (1.56%)
Oct 23, 2026, 3:00 PM CST
| Market Cap | 3.61B -2.5% |
| Revenue (ttm) | 1.40B +9.2% |
| Net Income | 154.99M +10.5% |
| EPS | 1.14 +9.6% |
| Shares Out | 135.44M |
| PE Ratio | 23.41 |
| Forward PE | n/a |
| Dividend | 0.60 (2.25%) |
| Ex-Dividend Date | Jun 5, 2026 |
| Volume | 3,096,400 |
| Open | 26.00 |
| Previous Close | 26.27 |
| Day's Range | 25.03 - 26.75 |
| 52-Week Range | 21.90 - 30.80 |
| Beta | 0.32 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |